![Erin Foff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erin Foff
Teknisk/Vetenskaplig/F&U Direktör på
MAPLIGHT THERAPEUTICS, INC.
Förmögenhet: 4 M $ per 2026-07-31
Profil
Erin Pennock Foff is currently Chief Medical Officer at MapLight Therapeutics, Inc. since 2021.
Formerly, Dr. Foff was Executive Director-Clinical Development at ACADIA Pharmaceuticals, Inc. Education includes doctorates from Baylor College of Medicine and Sidney Kimmel Medical College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-17 | 312 261 ( 0,59 % ) | 4 M $ | 2026-07-31 |
Aktiva positioner av Erin Foff
| Företag | Position | Start |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-04-01 |
Tidigare kända positioner av Erin Foff
| Företag | Position | Slut |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Företagsledare/Principal | - |
Erin Foffs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
15
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
